Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 21,625 shares at $44.97 ($968K) on 2019-02-22, disclosed to the SEC on 2019-02-26.
Open-market sale of $968k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.11 | 5,575 | $246K | 25.4% |
| 2 | $44.97 | 16,050 | $722K | 74.6% |
| Total | $44.75 avg | 21,625 | $968K | 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |